Healthcare News

BUENA, N.J., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter...

The Company Will Exhibit Through a Virtual Booth to Present its Products, Product Lines, and Business Initiatives to a Broad Array of Top Tier Institutional Biotech Investors  NEW YORK, NY,...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...

The trademark application can be found at USPTO.gov by searching “Complete Vaccine” in the Trademark Electronic Search System (TESS)Ii-Key-SARS-CoV-2 vaccine enters GMP production for clinical...

THE WOODLANDS, Texas, Dec. 31, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today the commencement of patient dosing in RELIEF-PHN 1, a Phase 2 randomized,...

LOS ANGELES, Dec. 31, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Tongji Healthcare Group, Inc. (OTCMKTS:TONJ) (name change to “Clubhouse Media Group, Inc.” currently pending) (“Tongji,” “Clubhouse...

Pressmeddelande 31 december 2020 Immunicum AB (publ) erhåller särläkemedelsstatus, ODD, från FDA för ilixadencel för behandling av levercancer Immunicum AB (publ; IMMU.ST) tillkännager idag att...

Press Release 31 December 2020 Immunicum AB (publ) Receives FDA Orphan Drug Designation for Ilixadencel as a Treatment for Hepatocellular Carcinoma (HCC) Immunicum AB (publ; IMMU.ST) announced...

Company announcement – No. 64 / 2020 Copenhagen, December 31, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the...

Niwot, Colorado., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Global Healthcare REIT, Inc. (Currently in a rebranding effort to Selectis Health, Inc.) (OTC: GBCS) ("Selectis" or the "Company") is pleased to...